RHJA
HBIO icon

Rice Hall James & Associates’s Harvard Bioscience HBIO Stock Holding History

Rice Hall James & Associates’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-31,410
Closed -$1.19M – 308
2015
Q3 		$1.19M Buy
31,410
+340
+1% +$15.8K 0.08% 224
2015
Q2 		$1.77M Sell
31,070
-70
-0.2% -$3.98K 0.1% 213
2015
Q1 		$1.81M Buy
31,140
+856
+3% +$46K 0.1% 202
2014
Q4 		$1.72M Buy
+30,284
New +$1.44M 0.1% 222

Other funds holding HBIO

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Rice Hall James & Associates's HBIO Position: Q4 2015 in Review

Rice Hall James & Associates sold out of Harvard Bioscience (HBIO) in Q4 2015, closing a stake of 31,410 shares — an estimated $1.19M sold.

Rice Hall James & Associates first reported a position in HBIO in Q4 2014 and held it in 4 quarters. The position peaked at $1.81M in Q1 2015. 81 funds tracked by Wall St. Rank hold HBIO as of Q4 2015.

  • Rice Hall James & Associates reported no remaining Harvard Bioscience position as of Q4 2015 after selling out during the quarter.
  • Rice Hall James & Associates sold 31,410 Harvard Bioscience shares in Q4 2015, an estimated $1.19M.
  • Rice Hall James & Associates first reported a position in Harvard Bioscience in Q4 2014 and held it in 4 quarters.
  • Rice Hall James & Associates's Harvard Bioscience position peaked at $1.81M in Q1 2015.
  • 81 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2015.

Based on Rice Hall James & Associates's 13F filing for Q4 2015, filed 28 Jan 2016.